Medical Facilities Corporation

Yield per half year: -1.39%
Dividend yield: 2.25%
Sector: Healthcare

Medical Facilities Corporation

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
3.52 46.26 -92.38% 7.2 -51.09%
P/S 0.7811 4.39 -82.21%
P/BV 1.76 5.41 -67.55%
P/FCF 3.34 26.99 -87.63%
Ev/Ebitda 2.72 17.44 -84.42%
Ev/S 0.6769 4.5 -84.96%
Ev/FCF 2.94 39.19 -92.49%
E/P 0.2889 1.06 -72.78%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
24.91 23.21 7.3% 20.68 +20.43%
ROE 70.66 14.54 386.01%
ROA 20.96 7.4 183.36%
ROIC 0 14.06 -100%
ROS 22.17 11.1 99.71%
ROCE 42.86 17.57 144.01%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
9/10
0.8954 2.91 -69.25% 1.59 -43.81%
Nеt Debt/Ebitda -0.4185 0.0376 -1214.01%
Debt/Ratio 0.2135 0.2175 -1.84%
Debt/Equity 1.35 1.12 20.65%
Debt/Net Income 1.01 9 -88.82%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
5.63/10
2.25 1.7 32.64% 3.05 -26.15%
Number of years of dividend growth 0 1.85 -100%
DSI 0.7857 0.7795 0.7925%
Average dividend growth -35.4 -359.57 -90.15%
Average percentage for 5 years 3.05 3.31 -8.02%
Average percentage for payments 3408.99 151.74 2146.61%
Difference from average difference in sector 0.5537

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-8.9 356.39 -102.5%
Growth impulse Ebitda in 5 years -1.82 337.43 -100.54%
Growth impulse Net Income in 5 years 96.5 247.92 -61.08%
Growth impulse FCF in 5 years -4.25 229.5 -101.85%
Growth impulse EPS in 5 years 155.16 436.02 -64.41%
IP Score
6.53/10

Similar companies

Sinopharm Group Co., Ltd.

WuXi Biologics (Cayman) Inc.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription